Randomized trial of nursing home residents with pneumonia to assess if intramuscular cefepime is a safe, efficacious, and cost-effective alternative to once daily intramuscular ceftriaxone for the treatment of elderly nursing home residents who develop pneumonia and do not require hospitalization.
To compare the efficacy, safety, and pharmacoeconomics of cefepime versus ceftriaxone. Double-blind study of nursing home residents \>60 years of age with pneumonia. Patients were randomized to cefepime or ceftriaxone 1 gm q24h to be administered intramuscularly. After three days, responding patients could be switched to oral antibiotics. Main Outcome Measures: clinical success, adverse events, and cost-effectiveness ratios.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
69
cefepime hydrochloride 1gm IM q24h
ceftriaxone 1 gm IM q24h
CPL Associates,LLC
Buffalo, New York, United States
Total cost of all antibiotics.
Time frame: 7-14 days
Clinical efficacy, safety, and cost-effectiveness analysis of total healthcare costs.
Time frame: 7-14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.